Nuveen Asset Management LLC Has $269.51 Million Stake in Colgate-Palmolive (NYSE:CL)

Nuveen Asset Management LLC cut its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 5.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,964,564 shares of the company's stock after selling 168,921 shares during the quarter. Nuveen Asset Management LLC owned about 0.36% of Colgate-Palmolive worth $269,509,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Chicago Partners Investment Group LLC grew its holdings in shares of Colgate-Palmolive by 16.2% during the fourth quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company's stock worth $591,000 after buying an additional 943 shares in the last quarter. Aviva PLC lifted its stake in Colgate-Palmolive by 13.4% in the 4th quarter. Aviva PLC now owns 973,421 shares of the company's stock valued at $88,494,000 after acquiring an additional 114,855 shares in the last quarter. Peak Financial Advisors LLC acquired a new position in Colgate-Palmolive during the 4th quarter worth approximately $1,315,000. Impact Partnership Wealth LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $803,000. Finally, Barclays PLC raised its holdings in shares of Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently commented on CL shares. UBS Group increased their target price on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. Citigroup increased their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. Raymond James restated an "outperform" rating and issued a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Piper Sandler dropped their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a report on Monday, March 31st. Finally, JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $102.12.

Colgate-Palmolive Stock Performance

CL stock traded up $1.63 during midday trading on Friday, reaching $91.26. 4,650,320 shares of the company were exchanged, compared to its average volume of 4,658,290. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The firm has a market capitalization of $73.96 billion, a price-to-earnings ratio of 25.93, a price-to-earnings-growth ratio of 4.20 and a beta of 0.39. The business has a 50-day moving average price of $91.65 and a two-hundred day moving average price of $91.29. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The company had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. During the same quarter last year, the company posted $0.86 EPS. Colgate-Palmolive's quarterly revenue was down 3.0% compared to the same quarter last year. Equities research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend was Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's payout ratio is currently 58.76%.

Colgate-Palmolive declared that its Board of Directors has authorized a share buyback program on Thursday, March 20th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 6.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its shares are undervalued.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.